未登录返回期刊详情
Health care resource use in the management of patients with relapsed/refractory diffuse large B-cell lymphoma - Canadian perspective复发/难治性弥漫性大B细胞淋巴瘤患者管理中的医疗资源使用——加拿大视角
Guinan, Kimberly; Pelletier, Mathieu; Ham, Monika; Tankala, Dipti; Roc, Nancy Paul; Klil-Drori, Adi; Wang, Anthony W.; Fleury, Isabelle; MacDonald, David; Lachaine, Jean; Barakat, Stephane.png)
分享.png)
收藏 Efficacy of selpercatinib as a first-line treatment for RET-fusion positive non-small-cell lung cancer: a novel two-stage Bayesian network meta-analysi s塞尔帕卡替尼作为RET融合阳性非小细胞肺癌的一线治疗的疗效：一项新颖的两阶段贝叶斯网络meta分析Forsyth, Jessica E.; Khanal, Manoj; Kiiskinen, Urpo; Jyothi, Akkula; Goel, Rajat; Puri, Tarun; Ren, Shijie; Sonksen, Michael D.; Wang, Xiaofei; Jen, Min-Hua 分享 收藏 Advancements from the EVOLVE study for assessing real-world experience with eteplirsen, golodirsen and casimersen for the treatment of DMDEVOLVE研究在评估依特利森、戈洛迪森和卡西米森森治疗杜氏肌营养不良症真实世界经验方面的进展Tian, Cuixia; Grabich, Shannon; Veerapandiyan, Aravindhan; Scharf, Rebecca J.; Santra, Sourav; Hornibrook, Shane; Drummond, Kerri; Sehinovych, Ihor; Waldrop, Megan 分享 收藏 Network meta-analysis: relative clinical efficacy and safety of elafibranor versus seladelpar as second-line treatment for patients with primary biliary cholangitis琼斯，D.; 科姆比，E.; 奈特，H.; 拉斯基尔-欧文斯，V.; 任，S.; 赖特，T.; 博因，E.A.; 帕希利，A. 网络荟萃分析：作为原发性胆汁性胆管炎患者的二线治疗，elafibranor 相对于 seladelpar 的相对临床疗效和安全性。J. Comp. Eff. Res. 2026, 15, e250206. [Google Scholar] [CrossRef] [PubMed]Jones, David; Combe, Emily; Knight, Harun; Laskier-Owens, Vicki; Ren, Shijie; Wright, Tom; Boing, Elaine A.; Pashley, Alex 分享 收藏 Comparative safety of direct oral anticoagulants and low-molecular-weight heparin in patients with venous thromboembolism and cancer in Europe欧洲静脉血栓栓塞症合并癌症患者中直接口服抗凝剂与低分子量肝素的比较安全性Brodin, Ellen; Young, Annie; Langer, Florian; Alikhan, Raza; Timo, Lauri; Lambrelli, Dimitra; Nordstrom, Beth; Booth, Alison; Graham, Sophie; Mokgokong, Ruth; Jenkins, Aaron; Chaves, Jose; Dai, Feng; Subash, Rupesh; Lehne, Moritz; Ghiani, Marco; Mevius, Antje; Fliegner, Daniela; Gottsater, Anders 分享 收藏 Real-world evidence on the use of hospital resources for subcutaneous and intravenous trastuzumab administration in breast cancer patients at a referral public hospital in Mexico关于在墨西哥一家转诊公立医院中，乳腺癌患者皮下和静脉注射曲妥珠单抗使用医院资源的真实世界证据Fiordelisio, Tatiana; Valdes-Souto, Francisco; Valdes, Diana del-Rio; Hernandez, Diego Zamarron; Pulido, Karla Ramirez; Soto, Cristopher Alejandro Escamilla; Trejo, Yair Uriel Correa; Sanchez, Claudia Itzel Gutierrez; Gutierrez, Isabel Espino; Salinas, Claudia Haydee Arce 分享 收藏 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png)
